Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion type Assertion NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_head.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion wasGeneratedBy ECO_0000203 NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_provenance.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion wasDerivedFrom befree-20150227 NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_provenance.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion SIO_000772 17565237 NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_provenance.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion evidence source_evidence_literature NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_provenance.
- NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_assertion description "[In conclusion, there were no differences between the mutant AMPD1 allele carriers and CC homozygotes regarding surrogate values for atherosclerosis, endothelial function, dimensions and ejection fraction of the heart, glucose tolerance and other well-known cardiovascular risk factors, whereas plasminogen activator inhibitor-1 activity and von Willebrand levels were lower in the mutant AMPD1 allele carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606583.RAiFNJq13QaLyhUvaIiay7t5YoeUHaCDYIi9fOYyRdXn0130_provenance.